Celecoxib and GABA Cooperatively Prevent the Progression of Pancreatic Cancer In Vitro and in Xenograft Models of Stress-Free and Stress-Exposed Mice
暂无分享,去创建一个
M. Ullah | H. Schuller | Hussein A. N. Al-Wadei | M. Al-Wadei | Mohammed H. Al-Wadei | Mohammad F. Ullah | Hildegard M. Schuller
[1] T. Adrian,et al. Cyclooxygenases and Lipoxygenases as Potential Targets for Treatment of Pancreatic Cancer , 2001, Pancreatology.
[2] Verena Jendrossek,et al. Targeting apoptosis pathways by Celecoxib in cancer. , 2013, Cancer letters.
[3] Markus F Neurath,et al. Targeting the VEGF signaling pathway in cancer therapy , 2012, Expert opinion on therapeutic targets.
[4] M. Tsao,et al. The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through β-adrenergic transactivation of EGF receptors , 2005, Journal of Cancer Research and Clinical Oncology.
[5] W. Wu,et al. Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[6] G. Siegal,et al. Signal Transduction Cross-talk During Colorectal Tumorigenesis , 2006, Advances in anatomic pathology.
[7] R. DuBois,et al. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[8] Steven W. Cole,et al. Molecular Pathways: Beta-Adrenergic Signaling in Cancer , 2011, Clinical Cancer Research.
[9] T. Adrian,et al. Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer , 2003, Molecular Cancer.
[10] M. Grossbard,et al. Metastatic pancreatic cancer 2008: is the glass less empty? , 2008, The oncologist.
[11] W. Wu,et al. Functional Role of β-Adrenergic Receptors in the Mitogenic Action of Nicotine on Gastric Cancer Cells , 2006 .
[12] H. Schuller,et al. GABAB receptor is a novel drug target for pancreatic cancer , 2008, Cancer.
[13] R. Lefkowitz. The superfamily of heptahelical receptors , 2000, Nature Cell Biology.
[14] F. Holsboer,et al. Long-term behavioral and neuroendocrine alterations following chronic social stress in mice: Implications for stress-related disorders , 2008, Hormones and Behavior.
[15] I. Ellis,et al. Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival , 2010, Oncotarget.
[16] T. Fahey,et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. , 1999, Cancer research.
[17] H. Plummer,et al. Social Stress Promotes and γ-Aminobutyric Acid Inhibits Tumor Growth in Mouse Models of Non–Small Cell Lung Cancer , 2011, Cancer Prevention Research.
[18] Shadan Ali,et al. Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy , 2005, Molecular Cancer Therapeutics.
[19] H. Schuller. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? , 2009, Nature Reviews Cancer.
[20] P. Philip,et al. Defining New Paradigms for the Treatment of Pancreatic Cancer , 2011, Current treatment options in oncology.
[21] H. S. Kim,et al. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[22] P. Maisonneuve,et al. Risk factors for pancreatic cancer , 2005, Journal of cellular biochemistry.
[23] Fan Zhang,et al. Cyclooxygenase-2 is overexpressed in human cervical cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] Anil K Sood,et al. Impact of stress on cancer metastasis. , 2010, Future oncology.
[25] S. Lippman,et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] L. Playle,et al. The MEK/ERK pathway mediates COX‐2‐selective NSAID‐induced apoptosis and induced COX‐2 protein expression in colorectal carcinoma cells , 2002, International journal of cancer.
[27] M. Thun,et al. Aspirin use and pancreatic cancer mortality in a large United States cohort. , 2004, Journal of the National Cancer Institute.
[28] T. L. Drell,et al. The norepinephrine‐driven metastasis development of PC‐3 human prostate cancer cells in BALB/c nude mice is inhibited by β‐blockers , 2006, International journal of cancer.
[29] K. Kraft,et al. Beta-endorphin and catecholamine concentrations during chronic and acute stress in intensive care patients. , 1996, European journal of medical research.
[30] J. Shah,et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. , 1999, Cancer research.
[31] H. Schuller,et al. Pancreatic Cancer Cells and Normal Pancreatic Duct Epithelial Cells Express an Autocrine Catecholamine Loop that Is Activated by Nicotinic Acetylcholine Receptors α3, α5, and α7 , 2011, Molecular Cancer Research.
[32] A. Sahin,et al. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. , 2002, Cancer research.
[33] H. Plummer,et al. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. , 1999, Cancer research.
[34] H. Plummer,et al. Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention. , 2012, Carcinogenesis.
[35] Liz Y. Han,et al. Stress Hormone–Mediated Invasion of Ovarian Cancer Cells , 2006, Clinical Cancer Research.
[36] H. Schuller,et al. Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. , 2001, Carcinogenesis.
[37] I. Ellis,et al. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. , 2010 .
[38] Steven Piantadosi,et al. The prevalence of psychological distress by cancer site , 2001, Psycho-oncology.
[39] G. Colditz,et al. A prospective study of aspirin use and the risk of pancreatic cancer in women. , 2004, Journal of the National Cancer Institute.
[40] O. Werz,et al. Arachidonic Acid Promotes Phosphorylation of 5-Lipoxygenase at Ser-271 by MAPK-activated Protein Kinase 2 (MK2)* , 2002, The Journal of Biological Chemistry.
[41] Robert M. Sapolsky,et al. Why zebras don't get ulcers : a guide to stress, stress related diseases, and coping , 1994 .
[42] G. Gasparini,et al. Pancreatic cancer: from molecular signature to target therapy. , 2008, Critical reviews in oncology/hematology.
[43] G. Chrousos. Stress and disorders of the stress system , 2009, Nature Reviews Endocrinology.
[44] D. Tarin,et al. Oncogenic Ras/Src cooperativity in pancreatic neoplasia , 2011, Oncogene.
[45] Robert M. Sapolsky,et al. Why zebras don't get ulcers : an updated guide to stress, stress-related diseases, and coping , 1994 .
[46] H. Plummer,et al. Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid. , 2009, Carcinogenesis.
[47] S. Missailidis,et al. Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. , 2009, International immunopharmacology.
[48] M. Kay Washington,et al. Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells* , 2001, The Journal of Biological Chemistry.
[49] P. Unger,et al. Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. , 2000, Urology.
[50] K. Zänker,et al. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. , 2001, Cancer research.
[51] S. Gately. The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis , 2004, Cancer and Metastasis Reviews.
[52] M. Kulke,et al. Metastatic pancreatic cancer , 2002, Current treatment options in oncology.
[53] A. Sood,et al. New Directions in Reducing Stress Effects on Cancer , 2012, Cancer Prevention Research.
[54] H. Schuller,et al. Prevention of pancreatic cancer by the beta-blocker propranolol , 2009, Anti-cancer drugs.
[55] A. Grothey,et al. Cyclooxygenase-2: a novel target for cancer chemotherapy? , 2001, Journal of Cancer Research and Clinical Oncology.
[56] R. Bold,et al. The role of Akt activation in the response to chemotherapy in pancreatic cancer. , 2010, Anticancer research.
[57] Liz Y. Han,et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma , 2006, Nature Medicine.